Patients with treatment-refractory cancers who did not meet eligibility criteria for a pan-cancer clinical trial but received waivers allowing them to participate had similar outcomes to patients who participated without waivers, a new analysis revealed. The study, published online in Clinical Cancer Research, highlighted the potential benefits of broadening eligibility criteria for clinical trials...
.png)
Copyright © 2024 fu.ci. All Rights Reserved
